Home
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Dementia

Management of aggression, agitation and behavioural disturbances in dementia: carbamazepine

Evidence summary [ESUOM40] Published: 10 March 2015

Advice

This evidence summary has been updated and replaced by NICE guideline NG97.